- Research article
- Open Access
- Open Peer Review
Antibacterial activity of selected Malaysian honey
BMC Complementary and Alternative Medicinevolume 13, Article number: 129 (2013)
Antibacterial activity of honey is mainly dependent on a combination of its peroxide activity and non-peroxide components. This study aims to investigate antibacterial activity of five varieties of Malaysian honey (three monofloral; acacia, gelam and pineapple, and two polyfloral; kelulut and tualang) against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa.
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) were performed for semi-quantitative evaluation. Agar well diffusion assay was used to investigate peroxide and non-peroxide activities of honey.
The results showed that gelam honey possessed lowest MIC value against S. aureus with 5% (w/v) MIC and MBC of 6.25% (w/v). Highest MIC values were shown by pineapple honey against E. coli and P. aeruginosa as well as acacia honey against E. coli with 25% (w/v) MIC and 50% (w/v) MBC values. Agar inhibition assay showed kelulut honey to possess highest total antibacterial activity against S. aureus with 26.49 equivalent phenol concentrations (EPC) and non-peroxide activity of 25.74 EPC. Lowest antibacterial activity was observed in acacia honey against E. coli with total activity of 7.85 EPC and non-peroxide activity of 7.59 EPC. There were no significant differences (p > 0.05) between the total antibacterial activities and non-peroxide activities of Malaysian honey. The intraspecific correlation between MIC and EPC of E. coli (r = -0.8559) was high while that between MIC and EPC of P. aeruginosa was observed to be moderate (r = -0.6469). S. aureus recorded a smaller correlation towards the opposite direction (r = 0.5045). In contrast, B.cereus showed a very low intraspecific correlation between MIC and EPC (r = -0.1482).
Malaysian honey, namely gelam, kelulut and tualang, have high antibacterial potency derived from total and non-peroxide activities, which implies that both peroxide and other constituents are mutually important as contributing factors to the antibacterial property of honey.
Two important enzymes known to contribute to the major biological activities of honey are bee-origin glucose oxidase and floral-origin catalase . These enzymes are crucial in determining the level of peroxide activity in honey which underlies numerous biological functions, including antibacterial potency. A high amount of active glucose oxidase will hydrolyze glucose to produce hydrogen peroxide (H2O2) resulting in oxidative stress which is beneficial in controlling bacterial colonization. In contrast, a high catalase level together with high antioxidant capacity will destroy H2O2 and serve as the principle guarding mechanism in order to conserve the nutritional value of honey.
However, in undiluted honey, glucose oxidase is inactive . Therefore, with assistance from various antioxidant constituents, H2O2 level in undiluted honey is said to be minimized. Very high osmotic pressures coupled with high acidity are the two main factors contributing to the antibacterial properties of honey at this stage [2, 3]. When honey is diluted to certain extents, glucose oxidase will be activated and start to utilize glucose to produce H2O2. At this point, the antibacterial activity of honey will gradually shift from osmotic- and pH-dependent to peroxide-dependent. Some types of honey, such as manuka honey from New Zealand, possess high non-peroxide antibacterial activity that can retain antibacterial potency even after removing the peroxide component from diluted honey [3, 4]. This is known as active non-peroxide honey which contains numerous non-peroxide constituents that support antibacterial actions. These include phenolic compounds, flavonoids, antibacterial peptides, methylglyoxal, methyl syringate, antibiotic-like derivatives and other components present in trace amounts [5, 6]. Not all types of honey exhibit non-peroxide activity. Some are strongly peroxide-dependent and possess very low antibacterial action when treated with catalase to remove peroxide activity [3, 4, 7].
To date, various studies have been conducted to investigate the antibacterial properties of honey from different parts of the world [4, 7–13]. White et al. proposed that inhibines, the antibiotic system in honey, were linearly related to H2O2 accumulation while Allen et al. subsequently described non-peroxide antibacterial activity in selected New Zealand honey. Limited studies have been done on Malaysian honey. In brief, Tan et al. compared the antibacterial activity of tualang honey with manuka honey from New Zealand while Aljadi et al. isolated and identified phenolic acids from gelam and coconut honey and tested them for their antibacterial activity. Tumin et al. studied antibacterial activities of five local honey varieties, namely, tualang, hutan, gelang, pucuk daun and Ee Feng Gu against various pathogenic bacteria strains.
The emergence of antibiotic-resistant bacteria has drawn major attention among healthcare and medical practitioners ever since the discovery of penicillin in the late 1920s . Several types of bacteria have been reported to develop new strains which survive antibiotics, including staphylococci, enterococci and mycobacteria. The situation became worse when multidrug resistant strains were discovered during the first decade of the 21st century . At the same time, healthcare-associated infections became a serious problem in hospitals . Furthermore, the pharmaceutical industry failed to develop new antimicrobial agents to face the new threat due to the high cost of drug research. In Malaysia, Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli were recorded as among the most common healthcare-associated pathogens isolated from patients . These bacteria may also develop multidrug resistant strains in various circumstances as reviewed by Bereket et al. To combat this serious situation, honey seems to be a promising alternative. It has been reported to be effective against a wide range of clinically isolated multi-resistant bacteria, such as, Vancomycin-resistant Enterococci (VRE) and multi-resistant Pseudomonas aeruginosa[19, 20]. The fact that honey resistance has never been reported nor any toxicity or side effects, low cost of maintenance, and local availability confer valuable advantages to using honey as an alternative antimicrobial therapy .
This study investigated the antibacterial potential of five Malaysian honey varieties against four bacteria species, namely, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, which are widely known to cause multidrug-resistant healthcare-associated infections, as well as Bacillus cereus to represent the spore-forming bacteria species known to cause food poisoning [17, 18, 21, 22].
Honey samples were obtained from local apiarists and stored in the dark at room temperature. The identification was performed by the bee hunters based on their geographical hunting area and floral availability at the location of bee hives (foraging radius). These were supported by organoleptic confirmation of the honey. The five types of honey used were: (i) acacia; honey derived from a plant widely used in the forest plantation industry from Sarawak state of Malaysia known as tropical acacia species or Acacia mangium, (ii) gelam; honey derived from mangrove swamp in Johore state known as Melaleuca cajuputi powell, (iii) kelulut; this type of honey is harvested by a stingless bee species, Trigona spp., and derived from multifloral foraging activity of bees, (iv) pineapple; a monofloral variety derived from pineapple flowers, Ananas comosus, and (v) tualang; a wild polyfloral honey produced by Apis dorsata located on one of the tallest tropical rainforest trees from species Koompassia excelsa. To ascertain the reproducibility and reliability of our study, the standard commercially available medical grade honey derived from manuka tree was included (Comvita Wound Care UMF 18+, New Zealand).
Cultures of bacteria were supplied by Microbiology Laboratory, University of Malaya Medical Centre (UMMC). Bacillus species was obtained from Molecular Bacteriology Laboratory, Department of Biomedical Science, University of Malaya. All bacteria were of standard strains (ATCC, US) comprising two Gram-positive bacteria; Staphylococcus aureus (ATCC 25923) and Bacillus cereus (ATCC 11778) and two Gram-negative bacteria; Escherichia coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853). Bacteria supplied were reconstituted into Trypticase Soy broth, TS (Difco,US) and incubated at 37°C. After 24 hours, they were sub-cultured on Mueller Hinton Agar, MH (Lab M, UK) and incubated again at 37°C for another 24 hours before being processed for long storage at -80° in cryogenic vials (Nalgene, US) containing brain Heart infusion broth, BHI (Difco, US) and 15% glycerol (R & M Chemicals, UK).
Working bacterial culture was prepared by inoculating a loopful of primary culture from -20° storage into universal bottle containing 10 ml of TS broth. The inoculum was incubated at 37°C for 24 hours before proceeding to subsequent assay.
Reagents and chemicals
All reagents and chemicals were of analytical grade or better. The diluent used in this study was sterile deionized distilled water (Merck Milipore, US), unless stated otherwise. Artificial honey was prepared by dissolving 40.5% fructose (sigma, US), 33.5% glucose (sigma, US), 7.5% maltose (sigma, US) and 1.5% sucrose (sigma, US) in a final volume of 100 ml sterile deionized distilled water .
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
The MIC test was adapted from Patton et al. and Tan et al. with slight modifications. Working bacteria culture was prepared as previously described, adjusted to be equal to 0.5 McFarland standard (1 × 108 cfu/ml) and further diluted by mixing 1 part of adjusted culture with 199 parts of TS broth to meet 5 × 105 cfu/ml. Volumes of 10 ml TS broth was pipetted into five sterile screw-capped test tubes and labeled accordingly. Another empty tube served as the first tube of honey stock solution where it was used to prepare 50% (w/v) honey solution by weighing 5 g honey sample, made up to 10 ml with TS broth, well mixed and filtered through 0.2 μm filters (Sartorius AG, Germany). A Two-fold serial dilution was prepared using all five pre-filled tubes together with four extra tubes containing honey dilutions of 5, 10, 15 and 20% (w/v). All tubes were vortex (Digisystem Laboratory Instruments Inc., Taiwan) until uniformly mixed. A volume of 190 μl of each honey dilution was aseptically transferred into 96 well flat-bottom microtitre plates (Nunc, Denmark) in eight replicates per dilution. The first two wells of every honey dilution served as dilution sterility controls (added with another 10 μl of respective honey dilution) and six others were the test wells in which 10 μl bacteria culture was mixed. Row number 11 and 12 were reserved for batch sterility and growth controls. Volume of 200 μl TS broth was used as assay sterility control in all wells of row 11 while 10 μl bacteria culture in 190 μl TS broth served as the assay growth control in all wells of row 12. Plates were incubated in a shaker incubator (Stuart, UK) at 120 rpm, 37°C for 24 hours. The absorbance of the wells was read at 590 nm using microtitre plate reader (Bio-rad, US) after incubation. The percentages of inhibition of bacteria growth were calculated by using the following formula:
Standards were prepared according to well-established two-fold dilution method comprising phenol (sigma, US), ampicillin (10 mg/L; sigma, US), ciprofloxacin hydrochloride (5 mg/L; Bayer Healthcare Pharmaceuticals, US) and tetracycline (30 mg/L; sigma, US) [24, 25].
MBC test was performed after MIC assay via streak plate method. Each honey dilution with no bacteria growth from the MIC test was determined. For each honey concentration with no bacteria growth, two wells of the corresponding honey dilution were randomly selected and one loopful bacteria suspension was transferred from each well onto two separate MH agars. It was spread evenly and incubated at 37°C for 24 hours. MBC were determined by the minimum concentration that allowed less than 1% of bacterial growth.
Agar well diffusion assay
The assay method was adapted from Allen et al. with slight modifications. Volumes of 150 ml nutrient agar, NA (Difco, US) was prepared according to manufacturer’s instructions. It was allowed to cool after autoclaving (at high pressure, 121°C for 10 minutes) and standing at 50°C before being seeded with 100 μl of 24 hours bacteria culture (prepared to meet absorbance of 0.5 measured at 540 nm using TS broth as diluent and blank). After uniform swirling, the agar was poured into large square bioassay dishes (245 × 245 × 25 mm; Nunc, Denmark). Solidified plates were stored overnight at 4°C upside down to be used the following day. Wells were cut into the agar using a sterile cork borer with 8 mm diameter.
Honey samples were freshly prepared for each assay and filter-sterilized with 0.2 μm filters. Twenty five percent (w/v) honey in deionized distilled water was prepared for the total activity test and 25% (w/v) honey in catalase solution (5 mg/mL, Fluka, Germany) for the non-peroxide activity test. Aliquots of 100 μl well-mixed honey samples were transferred randomly into each corresponding well in quadruplicate. Sterile deionized distilled water and catalase solution were used as a blank in duplicates for every plate. Phenol standards 1% (w/v) to 10% (v/v) were prepared and transferred in the same manner as the samples application. Phenol standards can be used up to one month when stored at 4°C. Plates were then incubated at 37°C for 24 hours. Ampicillin (10 μg), ciprofloxacin (5 μg) and tetracycline (30 μg) were included to ascertain the reproducibility and reliability of the assay and the bacterial resistant profiles.
The diameter of zones of inhibition of the wells was measured using digital vernier calipers (Mitotoyo, Japan) by measuring them in at least 2 directions perpendicular to each other (90°). The measurements were performed before all the samples and standards were re-identified to avoid bias. The mean of diameters of inhibition zone for each well and honey sample was calculated and squared. A standard curve was plotted of phenol concentration (%, v/v) against the mean of square diameter of inhibition zone. The best-fit linear line was drawn and the equation generated was used to calculate honey antibacterial activity from the readings obtained (Excel, Microsoft Corporation, US) expressed as Equivalent Phenol Concentration, EPC (%, w/v).
Catalase effectiveness test (removal of H2O2 confirmation)
Gelam and tualang honey were chosen to test the effectiveness of catalase using the method by Allen et al.. In brief, 6 tubes of test solution were prepared and labeled: tube 1 (25% (w/v) honey solution, 45 mmol/L H2O2 and 5 mg/mL catalase solution), tube 2 (25% (w/v) honey solution and 5 mg/mL catalase solution), tube 3 (45 mmol/L H2O2 and 5 mg/mL catalase solution), tube 4 (25% (w/v) honey solution and 45 mmol/L H2O2), tube 5 (25% (w/v) honey solution and tube 6 (45 mmol/L H2O2). Solutions then were tested in the same way as agar well diffusion assays on the same plate, and the diameters of clear zones (mm) were recorded.
Student’s t-test with two-tailed distribution (Excel, Microsoft Corporation, US) was used to compare total and non-peroxide activities of Malaysian honey. Pearson’s correlation (Excel, Microsoft Corporation, US) was performed to evaluate the association between diameter of inhibition zones expressed in EPC and minimum inhibitory concentration (MIC) expressed in percentage (%, w/v).
The MIC and MBC values of Malaysian honey against the four tested bacteria are shown in Table 1. Gelam honey was recorded as the most potent honey against S. aureus, in which a dilution of only 5% (w/v) was required to inhibit and kill them at 6.25% (w/v). The highest concentration required was 15% (w/v) to simultaneously inhibit and kill B. cereus. Interestingly, kelulut honey demonstrated constant MIC and MBC results at 20% (w/v) for all tests. Tualang honey closely resembled New Zealand Manuka honey (Comvita UMF 18+). The only difference between them was detected against B. cereus whereby tualang exerted slightly higher MIC and MBC values. Acacia honey had the lowest antibacterial potency to all bacteria tested except for E. coli, against which pineapple honey was least effective. Overall, the bactericidal activities of Malaysian honey were recorded to be one reading higher than their inhibitory effects with the exception of kelulut honey. Results of artificial honey showed that all bacteria were inhibited at 50% (w/v) concentration and no bactericidal effect was recorded. Phenol standards were found to be effectively inhibit bacterial growth at very low concentration, as low as 0.5 to 1% (w/v), while MBC was as low as 1 to 2% (w/v) only. Figure 1 displays the details of bacterial growth response against Malaysian honeys in MIC test. All bacteria showed dose–response activity in various degrees. Kelulut honey appeared most consistent in inhibiting bacterial growth regardless of their species. This was proven by the growth inhibition curve (Figure 1c) showing stable or similar increments in inhibition percentage of bacterial growth with little difference between bacteria species compared to other types of honey. In general, bacterial growth inhibition started at a level below MIC50 and increased gradually with honey concentration until it reached 100%. At low concentrations of acacia honey (1.6 and 3.1%, w/v) and pineapple honey (1.6% w/v), negative values were recorded (Figures 1a &1d) against B. cereus.
Table 2 shows measurements of EPC of Malaysian honey against four tested bacteria in terms of total activity and H2O2 exclusion activity. Four sets of the data showed very high activities, i.e., over 20 EPC. These were kelulut honey against S. aureus and the other three, namely, gelam, tualang and manuka (+18) honey against B. cereus. Three sets of data showed low antibacterial activities (below 10 EPC) - acacia honey against E. coli and P. aeruginosa, and pineapple honey against E. coli. Kelulut honey against E. coli showed total activity over 10 EPC but non-peroxide activity below 10 EPC. Comparisons between total and non-peroxide activities of Malaysian honey are shown in Figure 2. The differences between the two sets of data of the same honey were apparently not far apart except for acacia honey against B. cereus (Figure 2d). Furthermore, as all the differences were not statistically significant (p > 0.05), based on student’s t-test with 2-tailed distribution to compare total and non-peroxide activities, the data were not presented.
The scatter plot (Figure 3) demonstrates a pattern of antibacterial effect for each bacteria species tested. Whilst correlations (r) between MIC and EPC of P. aeruginosa were observed to be moderate (r = -0.6469), S. aureus also recorded moderate correlations, but towards the opposite direction (r = 0.5045). E. coli however, showed a high r value (r = -0.8559) indicating a strong correlation between MIC value and EPC. In contrast, there was no correlation at all between MIC value and EPC for B. cereus (r = -0.1483). All data were distributed randomly across the plotted area suggesting no direct correlation between the four tested bacteria population and the five Malaysian honey varieties (r = -0.2848).
The antibacterial activity of honey has been assayed using various methods across the globe with special attention devoted to agar diffusion assay and minimum inhibitory concentration (MIC) coupled with minimum bactericidal concentration (MBC). In this study, MIC was performed using 96-well microtitre plate and data were collected by means of a spectrophotometric endpoints evaluation. This method was chosen based on a number of reasons, including high sensitivity, reproducibility and repeatability, less time consumption, reduced cost, fewer amounts of sample and reagent required, and most importantly, less subjectivity as it does not involve human observations with the naked eye. Authors Patton et al., Brudzynski et al. and Sherlock et al. used T24-T0 different time comparison to measure the antibacterial effect of honey. In our preliminary test, T24-T0 different time comparisons showed a critical problem of inconsistency in the results recorded. In honey sterility control wells, the final readings (T24) deviated from initial readings (T0) detected. Some honey gave increased spectrophotometric readings while others showed otherwise even though at high honey concentration, this was expected to be constant due to the absence of bacterial growth. We suspected this could be due to volatile compounds present in honey [27–29]. At initial time (T0), these compounds were still in a complex mixture within the honey solution, hence, were measured as part of the sample. After 24 hours, under incubation temperature of 37°C, some volatile compounds could have evaporated, thus, affecting the measurements recorded. A significant reduction in the spectrophotometric reading led to false evaluation of bacterial growth. The degree of reduction of spectrophotometric readings was suggested to be dependent on the amount of volatile compounds in honey. As a complex mixture of different molecules and compounds, the other chemical constituents of honey might also affect its absorbance, including minerals, peptides, amino acids and alkaloids which can produce major interference . Therefore, this method of measurement was avoided and single endpoints (T24) method of measurement was chosen.
MIC is defined as the lowest concentration of honey that prevents at least 99% of bacterial growth while MBC is defined as the lowest concentration of honey required to kill at least 99% of the bacteria. Equal bacteriostatic and bactericidal effects of kelulut honey deviated from all other readings whereby all of them exhibited higher MBC value than MIC. The findings suggest that kelulut honey has different effects on the tested bacteria regardless of their species and survival abilities. This could be due to the presence of different organic antibacterial factors contributed by stingless bee (Trigona spp) rather than the usual honey bee (Apis spp), as well as the floral origin of the nectar [7, 27]. Previous findings reported by Tan et al. stated that manuka honey (Korde l’s, UMF 10+) exhibits higher antibacterial activity than tualang honey against S. aureus, E. coli and P. aeruginosa. In comparison, our study obtained a lower MIC for tualang honey against three bacteria, S. aureus, E. coli and P. aeruginosa probably due to different batch of honey and technical variations. Nonetheless, the pattern of antibacterial response of this particular honey was in agreement, i.e., S. aureus was found to be the most susceptible bacteria, followed by P. aeruginosa and E. coli.
MIC50 was defined as the concentration of honey required to inhibit bacterial growth by 50%. We included the MIC50 value in our data presentation (Figure 1) to give a clearer picture of bacterial growth inhibition patterns. Stimulation of B. cereus growth, denoted by negative values (Figures 1a & d), in low concentrations of acacia and pineapple honey might be due to the concentration of glucose which is sufficient to support B. cereus growth but not concentrated enough to inhibit them by osmotic pressure. At the lowest honey concentration tested, most honey inhibited more than 20% of bacterial growth with a few exceptions. B. cereus was the most unaffected bacteria when treated with low honey concentration, except for kelulut and manuka honey. Despite the adaptive ability of Bacillus species which are capable of withstanding alteration of their surrounding environment by forming spores, B. cereus were still inhibited and eventually killed by all types of honey tested . However, no further test was done to ascertain whether B. cereus were totally killed or were sporulating to withstand the antibacterial effects of honey.
Agar diffusion assay for antibacterial activity test is usually performed in three different ways - well/cup diffusion, disk diffusion or agar dilution. The method of choice usually depends on the nature of antibacterial agents to be tested and the kinetic properties of molecules inside. In our study, we decided to use well diffusion assay because honey is a complex solution consisting of different sizes of chemicals and compounds . The use of disk could lead to the exclusion of large molecules which are not properly absorbed by the paper disks and may contribute to inaccurate results. Agar well exercise allows direct contact of honey components and bacteria immediately after application. The diffusion mechanism may also represent in-vivo conditions when honey is applied on infected wounds, and therefore, may provide information about the kinetic system of honey application. This method was performed to evaluate the antibacterial activity of Malaysian honey at fixed concentration (qualitatively) compared to semi-quantitative evaluation by MIC/MBC tests. Specifically, S. aureus was most susceptible to kelulut honey, E. coli was most affected by gelam honey, P. aeruginosa was equally susceptible to tualang and manuka (+18) honey and B. cereus was highly vulnerable to tualang honey. Our findings also recorded that some Malaysian honey have higher antibacterial activity compared to well-known manuka (+18) honey as proven by kelulut honey against S. aureus (Figure 2a) and gelam honey against E. coli (Figure 2b).
In this study, H2O2 was removed from the honey solution to measure the antibacterial effect of honey without the presence of peroxide molecules . Student’s t-test with 2-tailed distribution was used to compare total and non-peroxide activities of Malaysian honey. The data were not presented because all of the differences were not statistically significant (p > 0.05). From these calculations, Malaysian honey was shown to have high non-peroxide activity. The antibacterial activity was not affected significantly by the absence of H2O2. They were just slightly reduced to some extent (Figure 2) indicating that H2O2 is still one of the major components of honey’s antibacterial system. Some of the readings from agar diffusion assay generated interesting information compared to MIC/MBC values. For example, kelulut honey exerted high MIC/MBC values (20%, w/v) which theoretically means poor antibacterial effect, but gave large zones of inhibition on agar diffusion assay, especially against S. aureus, indicating high antibacterial activity. This contradicting result between the two assays might be due to the properties of their chemical constituents. At high honey concentration, particularly concentrations above MIC value, they easily diffuse throughout the agar and inhibit bacterial growth in a large area. The variation in chemical composition might possibly be due to the unique property of kelulut as mentioned earlier. Further analysis on the chemical composition of antibacterial compounds is required to elucidate this. Contradicting results were also detected in the MIC/MBC assays against EPC measurement for B. cereus. High values of MIC/MBC data (Table 1) were recorded for this particular bacteria indicating poor antibacterial effect while agar diffusion assay showed high EPC value (Table 2), especially for gelam, kelulut, tualang and manuka (+18). This was the reason why we found no association at all between MIC and EPC of B. cereus (Figure 3). A possible explanation might be the adaptive ability of this species, as discussed earlier, which caused the bacteria to be highly affected at a particular level of honey concentration while remaining unaffected at low concentrations.
Our study emphasized that even though honey has high antibacterial potency against some bacteria species, it was not conclusive that they were both quantitatively and qualitatively excellent. In theory, low MIC value should give high EPC value since both are expected to have a high antibacterial potency. As such, the scatter plot (Figure 3) should illustrate a negative correlation between the two. From our data, S. aureus had deviated from this hypothesis with opposite results while B. cereus was totally in disagreement. This might due to kelulut honey which was considered an outlier. Exclusion of kelulut’s data resulted in a negative correlation with r = -0.7780 for S. aureus (data not shown) which was supports our hypothesis. Apparently, kelulut honey is unique and should be tested and analysed separately from the blossom honey. Our findings concurred with the latest antibiotic resistance issue, i.e., the serious therapeutic challenge presented by Gram-negative bacteria, P. aeruginosa and E. coli, due to its bacterial adaptive mechanism against current available antibiotics . This situation suggests that Gram-negative bacteria are less susceptible to available antibiotics compared to Gram-positive bacteria, which is consistent with our data as shown in Tables 1 and 2.
Honey sample for our study only involved one batch representing each type of Malaysian honey. A larger sample size should be tested and analysed in order to obtain a better picture about their correlation. According to Molan PC , a small number of samples does not represent a particular source of honey as a whole. Therefore, this present study was considered more likely to be a preliminary screening of Malaysian honey for their antibacterial potency. Our study used standard laboratory strains because there are very limited studies reporting on the five types of Malaysian honey of interest (acacia, gelam, kelulut, pineapple and tualang) against these bacteria species. S. aureus was included as it is widely used as the standard Gram-positive strain of preliminary assay with E.coli representing the Gram-negative strain [4, 7, 23, 25, 30]. P. aeruginosa represented a prominent healthcare-associated pathogen and B. cereus was chosen to represent spore-forming species which might also became clinically important particularly in food poisoning [16, 21]. To assess the antibacterial potency of these five Malaysian honey against antibiotic-resistant strains, further investigations should be conducted against antibiotic resistant and clinically isolated strains. The effect of these honey varieties on biofilm of bacteria should also be carried out since the present study only testes their effect against planktonic bacteria. Reproducibility and repeatability of the test were verified using commercially available Comvita +18 UMF manuka honey against standard strains, S. aureus (ATCC 25923). Allen et al. stated that +18 UMF means that the honey contains at least 18% (w/v) phenol equivalents of non-peroxide activity. This study proved to be reproducible when Comvita +18 Manuka Honey was assayed resulting in 18.38 UMF, sd ± 0.14%. Artificial honey was used to demonstrate the osmotic effect of honey against bacteria preferably to exclude the osmotic factors of natural honey. MIC and diameters of inhibition zones for all antibiotics were reproduced for susceptible strains of all bacteria tested as determined by Clinical Laboratory Standard Institute (CLSI) (data not shown [24, 31–33]). The effectiveness of catalase was assayed to affirm that the catalase added was working well in removing all H2O2 molecules and its activity was not affected by other components (Table 3).
The antibacterial potencies of Malaysian honey were generally comparable with well-known New Zealand manuka honey, with close resemblance by tualang honey. Agar diffusion assay proved that all Malaysian honey possess high non-peroxide antibacterial activity. Malaysian honey, namely gelam, kelulut and tualang honey have high antibacterial potency of total and non-peroxide activities implying that peroxide and other constituents are mutually important as contributing factors to the antibacterial system of honey. The correlations between MIC and EPC value of Malaysian honey were proven to be dependent on bacteria species and honey origin. The spore-forming bacteria, B. cereus, were found to be affected differently by Malaysian honey as compared to other bacteria species. Kelulut honey has quantitatively poor but qualitatively excellent antibacterial potency. Gram-positive bacteria proved to be more susceptible to Malaysian honey compared to Gram-negative bacteria species.
White JW, Subers MH, Schepartz AI: The identification of inhibine, the antibacterial factor in honey, as hydrogen peroxide and its origin in a honey glucose-oxidase system. Biochim Biophys Acta. 1963, 73: 57-70. 10.1016/0926-6569(63)90108-1.
Molan PC: The antibacterial activity of honey 1. The nature of antibacterial activity. Bee World. 1992, 73 (1): 5-28.
Molan PC: The antibacterial activity of honey 2. Variation in the potency of the antibacterial activity. Bee World. 1992, 73 (1): 59-76.
Allen KL, Molan PC, Reid GM: A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol. 1991, 43: 817-822. 10.1111/j.2042-7158.1991.tb03186.x.
Jaganathan SK, Mandal M: Antiproliferative effects of honey and of its polyphenols: a review. J Biomed Biotechnol. 2009, Available: http://www.hindawi.com/journals/jbb/2009/830616. Accessed 04 February 2011
Mandal MD, Mandal S: Honey: its medicinal property and antibacterial activity. Asian Pasific J Trop Biomed. 2011, 154-160. Available: http://apjtb.com/zz/April/16.pdf. Accessed 21 April 2012
Irish J, Blair S, Carter DA: The antibacterial activity of honey derived from Australian flora. PLoS One. 2011, 6: 3-Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018229. Accessed 02 February 2012
Basson NJ, Gronbler SR: Antimicrobial activity of two South African honeys produced from indigenous Leucospermum cordifolium and Erica species on selected micro-organisms. BMC Complement Altern Med. 2008, 8: 41-10.1186/1472-6882-8-41. Available: http://www.biomedcentral.com/1472-6882/8/41. Accessed 18 January 2012
Kucuk M, Kolayli S, Karaoglu S, Ulusoy E, Baltaci C: Biological activities and chemical composition of three honeys of different types from Anatolia. Food Chem. 2007, 100: 526-534. 10.1016/j.foodchem.2005.10.010.
Mundo MA, Padilla-Zakour OI, Worobo RW: Growth inhibition of foodborne pathogens and food spoilage organisms by select raw honeys. Int J Food Microbiol. 2004, 97: 1-8. 10.1016/j.ijfoodmicro.2004.03.025.
Tan HZ, Abdul Rahman R, Gan SH, Halim AS, Hassan SA: The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey. BMC Complement Altern Med. 2009, 9: 34-10.1186/1472-6882-9-34. Available: http://www.biomedcentral.com/1472-6882/9/34. Accessed 6 July 2011
Gomes S, Dias LG, Moreira LL, Rodrigues P, Estevinho L: Physicochemical, microbiological and antimicrobial properties of commercial honeys from Portugal. Food Chem Toxicol. 2010, 48: 544-548. 10.1016/j.fct.2009.11.029.
Sherlock O, Dolan A, Athman R, Power A, Gethin G: Comparison of the antimicrobial activity of Ulmo honey from Chile and manuka honey against methicillin-resistance Staphylococus aureus, Escherichia coli and Pseudomonas aeruginosa. BMC Complement Altern Med. 2010, 10: 47-10.1186/1472-6882-10-47. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942791. Accessed 22 November 2011
Aljadi AM, Mohd Yusoff K: Isolation and identification of phenolic acids in Malaysian honey with antibacterial properties. Turkish Can J Med Sci. 2003, 33: 229-236.
Tumin N, Abdul Halim NA, Shahjahan M, Noor Izani NJ, Sattar MA: Antibacterial activity of local Malaysian Honey. Malaysian Eur J Pharm Sci. 2005, 3 (2): 1-10.
Arias CA, Murray BE: Antibiotic-resistant bugs in the 21st century – a clinical super-challenge. N Engl J Med. 2009, 360: 439-443. 10.1056/NEJMp0804651.
Bereket W, Hemalathe K, Getenet B, Wondwossen T, Solomon A: Update on bacterial Nosocomial infections. Eur Rev Med Pharmacol Sci. 2012, 16: 1039-1044.
Hughes AJ, Ariffin N, Tan LH, Abdul Muluk H, Hashim S: Prevalence of Nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005, 26 (1): 100-104. 10.1086/502494.
George NM, Cutting KF: Antibacterial honey (MedihoneyTM): in-vitro activity against clinical isolated MRSA, VRE and other multi-resistant Gram-negative organism including Pseudomonas aeruginosa. Wounds. 2007, 19: 231-236.
Cooper RA, Molan PC, Harding KG: The sensitivity to honey of Gram-positive cocci of clinical signicficance isolated from wounds. J Appl Microbiol. 2002, 93: 857-863. 10.1046/j.1365-2672.2002.01761.x.
Bottone EJ: Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010, 23 (2): 382-398. 10.1128/CMR.00073-09.
: Opinion of scientific panel on biologycal hazards on bacillus cereus and other bacillus spp in foodstuff. The EFSA J. 2005, 175: 1-48.http://www.efsa.europa.eu/en/efsajournal/doc/175.pdf,
Patton T, Barrett J, Brennan J, Moran N: Use of spectrophotometric bioassay for determination of microbial sensitivity to manuka honey. J Microbiologocal Methods. 2006, 64: 84-95. 10.1016/j.mimet.2005.04.007.
NCCLS: NCCLS document M23-A2 [ISBN 1-56238-435-X]. Development of In vitro susceptibility testing criteria and quality control parameters; approved guideline - second edition. 2001, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA: NCCLS
Andrews JM: Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001, 48 (Suppl. S1): 5-16. 62
Brudzynski K, Abubaker K, Martin L, Castle A: Re-examining the role of hydrogen peroxide in bacteriostatic and bactericidal activities of honey. Front microbiol. 2011, 2: 213-Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201021/pdf/fmicb-02-00213.pdf. Accessed 20 April 2012
Anklam E: A review of the analytical methods to determine the geographical and botanical origin of honey. Food Chem. 1998, 63 (4): 549-562. 10.1016/S0308-8146(98)00057-0.
Bogdanov S: Nature and origin of the antibacterial substances in honey. Lebensm Wiss u Technol. 1997, 30: 748-753.
Manyi-Loh CE, Clarke AM, Ndip RN: An overview of honey: therapeutic properties and contribution in nutrition and human health. African J Microbiol Res. 2011, 5 (8): 844-852.
Bonev B, Hooper J, Parisot J: Principles of assessing bacterial susceptibility of antibiotics using the agar diffusion method. J Antimicrob Chemother. 2008, 61: 1295-1301. 10.1093/jac/dkn090.
Clinical Laboratory Standard Institute: CLSI document M45-P [ISBN 1-56238-583-6]. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; proposes guideline. 2005, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA: Clinical Laboratory Standard Institute
Clinical Laboratory Standard Institute: CLSI document M100-S17 [ISBN 1-56238-625-5]. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. 2007, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA: Clinical Laboratory Standard Institute
Clinical Laboratory Standard Institute: CLSI document M02-A11. Performance standards for antimicrobial disk susceptibility tests; approved standard – eleventh edition. 2012, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA: Clinical Laboratory Standard Institute
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/129/prepub
This study was supported by PPP grant (PV090/2012A) awarded by University of Malaya.
The authors declare that they have no competing interests.
MIZ planned, carried out the experiments, involved in data interpretation, and prepared the manuscript including revisions. MYMY design and planned the experiments in microbiological aspect, contributed in data interpretation and manuscript/revision editing. KMY acted as project leader and advisor of this study mainly in biochemical part of honey analysis, contributed in data interpretation and troubleshooting as well as manuscript and revision editing. All authors read and approved the manuscript.
About this article
- Antibacterial activity
- Malaysian honey
- Minimum inhibitory concentration (MIC)
- Minimum bactericidal concentration (MBC)
- Equivalent phenol concentration (EPC)
- Non-peroxide activity